Tenet Reports Results for the First Quarter Ended March 31, 2016

Go back to Tenet Reports Results for the First Quarter Ended March 31, 2016

Tenet Healthcare (THC) Tops Q1 EPS by 12c; Provides Q2, FY16 Guidance

May 2, 2016 5:16 PM EDT

Tenet Healthcare (NYSE: THC) reported Q1 EPS of $0.45, $0.12 better than the analyst estimate of $0.33. Revenue for the quarter came in at $4.4 billion versus the consensus estimate of $4.78 billion.

Generated Adjusted EBITDA of $613 million, a $0.56 loss per share from continuing operations, and, after adjusting for certain items, Adjusted diluted EPS of $0.45 during the first quarter of 2016.Same-hospital patient revenue grew 6.0% in the first quarter, driven by 2.2% growth... More